Drug Shortage Report for CLAVULIN 250 F ORAL SUS
Report ID | 75177 |
Drug Identification Number | 01916874 |
Brand name | CLAVULIN 250 F ORAL SUS |
Common or Proper name | amoxicillin / clavulanate potassium for oral suspension |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | AMOXICILLIN CLAVULANIC ACID |
Strength(s) | 250MG 62.5MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 1x100mL |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-02-06 |
Estimated end date | 2019-02-15 |
Actual end date | 2019-02-12 |
Shortage status | Resolved |
Updated date | 2019-02-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-02-08 | English | Compare |
v2 | 2019-02-08 | French | Compare |
v3 | 2019-02-13 | English | Compare |
v4 | 2019-02-13 | French | Compare |
Showing 1 to 4 of 4